The Valley Desk

NCT05165433 · Interventional trial

Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)

Overall registry status Completed

Phase 1

Conditions Epithelial Tumor, Metastatic Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov